Effect of Vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss

Makoto Owada, Kumiko Suzuki, Tsuyoshi Honda, Hidekazu Yamada, Susumu Tsukikawa, Kazuhiko Hoshi, Akira Sato

    研究成果: Article査読

    3 被引用数 (Scopus)

    抄録

    In order to assess the effect of vitamin D receptor (VDR) gene polymorphisms on vitamin D3 therapy for postmenopausal bone loss. Thirty- four Japanese postmenopausal women, administer ed vitamin D3 (Alfarol® 1.0μg/day) and Ca (2.0g/day) for 18 months, were analyzed by RFLP Bone mineral density (BMI) at the lumber spine (L2-4) and Os-calcis were measured every 6 months by dual energy X-ray absorptiometry (DXA) and single energy X-ray absorptiometry (SXA) VDR gene allelic polymorphisms were assessed by Bsm 1 endonuclease restriction after specific PCR amplification. Genotypic polymorphism was defined as BB, bb and Bb. The genotypes were BB in 1 (3.1%) Bb in 13 (40.6%) and bb in 18 (56.3%). The women in these two major VDR genotype groups (Bb and bb) were similar in their backgrounds (interms of age, menopausal age, body mass index, and BMD in premedication), but the VDR genotype was associated the percent of change in BMD after treatment. In Group-Bb, the mean percent increases in L2-4 BMD were 3.2%, 4.9% and 4.1% at 6, 12 and 18 months. In contrast, in Group-bb they were 0.8%, 1.8% and 4.2% at the same points. Analysis of VDR alleles may prove useful in selecting the vitamin D therapy for osteopenia before treatment.

    本文言語English
    ページ(範囲)799-805
    ページ数7
    ジャーナルActa Obstetrica et Gynaecologica Japonica
    48
    9
    出版ステータスPublished - 1996 9月

    ASJC Scopus subject areas

    • 産婦人科学

    フィンガープリント

    「Effect of Vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

    引用スタイル